NPPB and hydrops fetalis: Both BNP and N-terminal pro-B-type natriuretic peptide (NT-proBNP) have been extensively shown to contribute to the diagnosis and risk stratification of HF, and these biomarkers are increasingly utilized as tools for population screening (Castiglione et al., 2022).